On November 13th, the Xintian Shenzhen-Hong Kong Cooperation and Development Forum, hosted by Dystar Group, was held in the Shenzhen Futian International Biomedical Industrial Park. The forum centered around the development of the biomedical industry in the Loop Cooperation Zone and delved into the opportunities and challenges of cooperation between Xintian and the Loop Cooperation Zone in the field of biomedicine.

On that day, a number of Hong Kong political experts, including Mr. Lau Yip Keung, Chairman of the Hong Kong New Territories Heung Yee Kuk, Mr. Yau Wing Kwong, and Mr. Lau Man Kwan, members of the Hong Kong New Territories Heung Yee Kuk, participated in the forum. During the event, Mr. Lau expressed his active support for promoting the development of Hong Kong’s New Territories North Metro Area. He also expressed hope to strengthen ties with Shenzhen and explore collaboration in areas such as science and technology innovation, biomedicine, and more. The goal is to contribute to the development of the Loop Cooperation Zone.

Dr. Anjin Xianyu, Co-founder and CTO of META Pharmaceuticals, was also invited to participate in the event. Together with other representatives from biomedical enterprises, they engaged in an in-depth discussion on cross-border investment and financing, as well as the various possibilities of cooperation within the Xintian Loop. Following the forum, Chairman Liu Yeqiang and a group of representatives visited META Pharmaceuticals and highly recognized META’s new biological mechanism.